These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23293313)

  • 1. Politics vs practice: commentary on the ADHD debate.
    Levy F
    Aust N Z J Psychiatry; 2013 Jan; 47(1):89-91. PubMed ID: 23293313
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on Levy (2012) politics vs practice: withdrawal of the draft NHMRC ADHD guidelines.
    Starling J
    Aust N Z J Psychiatry; 2013 Jan; 47(1):91-2. PubMed ID: 23293314
    [No Abstract]   [Full Text] [Related]  

  • 3. Time for some reason in the ADHD debate.
    Starling J
    Aust N Z J Psychiatry; 2013 Oct; 47(10):958-9. PubMed ID: 23888075
    [No Abstract]   [Full Text] [Related]  

  • 4. ADHD debate clouded by preconceptions and undisclosed conflicts of interest.
    Whitely M
    Aust N Z J Psychiatry; 2013 Oct; 47(10):956-8. PubMed ID: 23888076
    [No Abstract]   [Full Text] [Related]  

  • 5. The ADHD debate: to bury national guidelines or to praise them?
    Paterson R
    Aust N Z J Psychiatry; 2013 Oct; 47(10):959-60. PubMed ID: 23888074
    [No Abstract]   [Full Text] [Related]  

  • 6. Child psychopharmacology: politics versus science.
    Levy F
    Aust N Z J Psychiatry; 2013 Oct; 47(10):961. PubMed ID: 23888073
    [No Abstract]   [Full Text] [Related]  

  • 7. ADHD in Western Australia: an iatrogenic 'epidemic' cured by bureaucracy? Time to focus on the facts.
    Paterson R
    Aust N Z J Psychiatry; 2013 Jan; 47(1):88-9. PubMed ID: 23293312
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Whitely: a caution from the coalface.
    Levy F
    Aust N Z J Psychiatry; 2012 May; 46(5):404-6. PubMed ID: 22535290
    [No Abstract]   [Full Text] [Related]  

  • 9. Bad Medicine: Psychiatric medicine.
    Spence D
    Br J Gen Pract; 2018 Dec; 68(677):583. PubMed ID: 30498152
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
    Salmelainen P
    N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic drug use in very young children.
    Coyle JT
    JAMA; 2000 Feb; 283(8):1059-60. PubMed ID: 10697069
    [No Abstract]   [Full Text] [Related]  

  • 12. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
    Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK
    J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADHD Medication Trends in Turkey: 2009-2013.
    Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
    J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Time Trends in the Frequencies of ADHD and Stimulant Medication].
    Steinhausen HC; Döpfner M; Schubert I
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):275-84. PubMed ID: 27434688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory action and moderate decrease in methylphenidate use among ADHD diagnosed patients aged five and under in Korea.
    Shin JY; Lee SH; Shin SM; Shin HN; Park BJ
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):244-8. PubMed ID: 25957571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of melatonin in Swedish children and adolescents--a register-based study according to age, gender, and medication of ADHD.
    Furster C; Hallerbäck MU
    Eur J Clin Pharmacol; 2015 Jul; 71(7):877-81. PubMed ID: 25995170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.
    Bachmann CJ; Wijlaars LP; Kalverdijk LJ; Burcu M; Glaeske G; Schuiling-Veninga CCM; Hoffmann F; Aagaard L; Zito JM
    Eur Neuropsychopharmacol; 2017 May; 27(5):484-493. PubMed ID: 28336088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing for ADHD in primary care.
    Rashid A; Llanwarne N; Lehman R
    Br J Gen Pract; 2018 Apr; 68(669):170-171. PubMed ID: 29592923
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
    Štuhec M; Locatelli I; Švab V
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.